Reuters: Money News: India board revokes GSK patent on breast cancer drug Tykerb

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

India board revokes GSK patent on breast cancer drug Tykerb Aug 2nd 2013, 05:41 MUMBAI (Reuters) - India's patent appeals board has revoked a patent granted to GlaxoSmithKline Plc's breast cancer drug Tykerb, which is a salt form of the original compound, lapatinib.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions